Booth Andrew
SEC CIK 1834411 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc. | CFO | 482.8K | $2.11M | — | 10 | 2021-11-11 | 2026-08-14 |
Most active insiders at ABCL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hayden Michael R | Dir | $1.05M | — |
| 2 | Thermopylae Holdings Ltd. | 10% | $711.0K | — |
| 3 | Booth Andrew | CFO | $529.6K | — |
| 4 | Montalbano John S. | Dir | $384.2K | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 12:04 | 2026-08-14 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $10.32 | +37.2K | 482.8K | +8% | +$383.9K | |
| D | 2026-06-03 14:23 | 2026-06-03 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | M - OptEx | $0.19 | +250.0K | 445.6K | +128% | +$47.5K |
| 2026-02-27 | 2026-02-27 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $3.42 | +42.6K | 195.6K | +28% | +$145.7K | |
| 2023-05-26 | 2023-05-26 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $6.85 | +14.5K | 153.0K | +10% | +$99.3K | |
| D | 2022-12-22 | 2022-12-20 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | G - Gift | $0.00 | -50.0K | 138.5K | -27% | $0 |
| D | 2022-12-22 | 2022-12-20 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | M - OptEx | $0.19 | +50.0K | 188.5K | +36% | +$9,500 |
| 2022-05-16 | 2022-05-12 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $5.79 | +85.0K | 138.5K | +159% | +$492.1K | |
| D | 2021-12-10 | 2021-12-10 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | M - OptEx | $0.32 | +500.0K | 553.5K | +935% | +$160.0K |
| I | 2021-11-15 | 2021-11-11 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $14.61 | +14.0K | 131.0K | +12% | +$204.5K |
| 2021-11-15 | 2021-11-11 | ABCL | AbCellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $14.74 | +53.5K | 53.5K | New | +$788.6K |
Purchase Sale Sale after option exercise All abbreviations